Articles
NANS Joins Multi-Society Effort on PNS Coverage
The North American Neuromodulation Society (NANS) joined several leading medical specialty societies in submitting joint letters to Cigna Healthcare and UnitedHealthcare regarding policies that classify peripheral nerve stimulation (PNS) as investigational for the treatment of chronic pain.
NANS Continues Coverage Advocacy on PNS
As part of its ongoing efforts to protect patient access to evidence-based therapies, NANS has submitted a formal comment letter to Cigna regarding Medical Coverage Policy 0539, which currently classifies Peripheral Nerve Stimulation (PNS) as “not medically necessary.”
NANS Leads Response Objecting to Cigna’s Depiction of PNS
In March, NANS learned about Cigna’s Medical Coverage Policy characterizing peripheral nerve stimulation (PNS) to treat chronic pain as “not medically necessary.” NANS led the response objecting to Cigna’s depiction of the treatment as lacking medical necessity.
New CIGNA Policy Calls Peripheral Nerve Stimulation “Not Medically Necessary”
In March, CIGNA released policy 0539, characterizing peripheral nerve stimulation (PNS) as “not medically necessary.” NANS is working with the PNS Subcommittee to respond to this categorization.
NANS’ Efforts Ensure Coverage for Closed-loop SCS with Cigna and EviCore
NANS led efforts on behalf of the Multi Society Pain Workgroup to object to insurers’ classification of closed-loop spinal cord stimulation (SCS) as experimental, investigational and/or unproven. Cigna and EviCore revised their policies to include coverage of closed-loop SCS.